跳转至内容
Merck
CN

主要文件

查看所有文档

87368-M

四氢呋喃

≥99.9%, ACS reagent, contains ~0.025% 2, 6-di-tert-butyl-4-methylphenol as stabilizer, 250 ppm BHT as inhibitor, suitable for solid phase extraction (SPE), reag. Ph. Eur.

别名:

丁烯氧化物, 四亚甲基氧化物, 氧杂环戊烷

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C4H8O
化学文摘社编号:
109-99-9
分子量:
72.11
NACRES:
NA.21
PubChem Substance ID:
329769580
UNSPSC Code:
12352005
EC Number:
203-726-8
MDL number:
MFCD00005356
Beilstein/REAXYS Number:
102391
Assay:
≥99.9%
Technique(s):
solid phase extraction (SPE): suitable
Bp:
65-67 °C (lit.)
Vapor pressure:
114 mmHg ( 15 °C), 143 mmHg ( 20 °C)
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

四氢呋喃, contains 250 ppm BHT as inhibitor, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.9%

Quality Level

200

agency

reag. Ph. Eur.

vapor density

2.5 (vs air)

vapor pressure

114 mmHg ( 15 °C), 143 mmHg ( 20 °C)

grade

ACS reagent, puriss. p.a.

assay

≥99.9%

form

liquid

autoignition temp.

610 °F

contains

250 ppm BHT as inhibitor, ~0.025% 2,6-di-tert-butyl-4-methylphenol as stabilizer

expl. lim.

1.8-11.8 %

technique(s)

solid phase extraction (SPE): suitable

impurities

≤0.001% free acid (as CH3COOH), ≤0.005% peroxides (as H2O2), ≤0.05% water

evapn. residue

≤0.001%

refractive index

n20/D 1.407

pH

~7

bp

65-67 °C (lit.)

mp

−108 °C (lit.)

density

0.887 g/mL at 20 °C, 0.889 g/mL at 25 °C (lit.)

SMILES string

C1CCOC1

cation traces

Al: ≤0.5 mg/kg, B: ≤0.02 mg/kg, Ba: ≤0.1 mg/kg, Bi: ≤0.1 mg/kg, Ca: ≤0.5 mg/kg, Cd: ≤0.05 mg/kg, Co: ≤0.02 mg/kg, Cr: ≤0.02 mg/kg, Cu: ≤0.02 mg/kg, Fe: ≤0.1 mg/kg, K: ≤0.5 mg/kg, Li: ≤0.1 mg/kg, Mg: ≤0.1 mg/kg, Mn: ≤0.02 mg/kg, Mo: ≤0.1 mg/kg, Na: ≤0.5 mg/kg, Ni: ≤0.02 mg/kg, Pb: ≤0.1 mg/kg, Sn: ≤0.1 mg/kg, Sr: ≤0.1 mg/kg, Zn: ≤0.1 mg/kg

InChI

1S/C4H8O/c1-2-4-5-3-1/h1-4H2

InChI key

WYURNTSHIVDZCO-UHFFFAOYSA-N

General description

The product is tetrahydrofuran (THF) and it contains 250ppm BHT (Butylated hydroxytoluene) as an inhibitor. THF is widely employed as a solvent. It constitutes the key fragment of various natural products (polyether antibiotics). THF forms double hydrate with hydrogen sulfide. Crystal structure of this double hydrate has been investigated by three-dimensional single-crystal studies. Butane-1,4-diol is formed as an intermediate during the synthesis of THF. Hot THF is useful for the dissolution of polyvinylidene chloride (PVDV).

Application

Tetrahydrofuran has been used as a solvent for the preparation of sol-gel solution for coating solid phase microextraction (SPME) fibers in a study.

It may be used for the dissolution of poly-ε-caprolactone (PCL) and 1,3-diaminopentane, during the preparation of poly-ε-caprolactone (PCL)-hydroxyapatite (HA) scaffolds and acrylate-terminated poly(5-amino-1-pentanol-co-1,4-butanediol diacrylate) (C32)- 1,3-diaminopentane (117) polymer, respectively.

Analysis Note

miscible with water and ethanol (96%) pass

Other Notes

可能实行销售限制

Still not finding the right product?

Explore all of our products under 四氢呋喃

Hazard Classifications

Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - STOT SE 3

target_organs

Central nervous system, Respiratory system

signalword

Danger

supp_hazards

EUH019

存储类别

3 - Flammable liquids

flash_point_f

1.4 °F - closed cup

flash_point_c

-17.00 °C - closed cup

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCN8669
SDBB4504
SDBB2383
SDBB1862
STBL3804

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Todd J Harris et al.
Biomaterials, 31(5), 998-1006 (2009-10-24)
The use of biomaterials for gene delivery can potentially avoid many of the safety concerns with viral gene delivery. However, the efficacy of polymeric gene delivery methods is low, particularly in vivo. One significant concern is that the interior and
Haiying Yu et al.
Biomaterials, 30(4), 508-517 (2008-11-01)
Natural bone growth greatly depends on the precedent vascular network that supplies oxygen and essential nutrients and removes metabolites. Likewise, it is crucial for tissue-engineered bone to establish a vascular network that temporally precedes new bone formation, and spatially originates